Clinical Trials Reform

The Department of Industry and Science and the Department of Health are working together to implement clinical trial reforms. These measures will improve efficiency, streamline administration and promote the standardisation of costs for clinical trials. The key areas for the Department of Industry are to enable greater participation and engagement in clinical trials through the development of a clinical trials interactive portal and support education and training to improve clinical trial conduct and timeliness of governance approvals.

Australian Government funding to implement reforms in clinical trials will ensure that the clinical research sector continues its contribution to the productivity of the health industry in Australia as well as supporting health outcomes for the Australian public. The reform initiative will advance Australia's position as a leader in clinical research and improve our attractiveness as a destination for clinical research investment. It is designed to ensure Australia maintains its competitive advantage as a global leader in clinical research and support the commercialisation of new medical technologies.
The clinical trial reform activities are aimed at completing and furthering the work on recommendations from the Clinical Trials Action Group (CTAG).

Reform Activities

The Government’s ongoing reforms to support the clinical research sector and the broader clinical trials industry will:

  • develop prices for a list of routine clinical trial items to help promote transparency of standard costs for clinical trials;
  • Incorporate clinical research needs into e-health systems;
  • enable greater participation and engagement in clinical trials through the development of a clinical trials interactive portal;
  • support education and training to improve clinical trial conduct and timeliness of governance approvals; and
  • facilitate the development of a nationally consistent approach to the way clinical trials are overseen and conducted.

View updated information and progress on the reform activities.

Clinical Trials Advisory Committee

The Clinical Trials Advisory Committee (CTAC) has been established to provide advice to the Department of Health and the Department of Industry and Science on the work program to progress implementation of each of the elements for clinical trials reform.

How do you find out about Clinical Trials?

The department funded the development of the Australian Clinical Trials website, australianclinicaltrials.gov.au, which is a joint project with the NHMRC. The website provides information about clinical trials of new drugs, treatments and medical procedures and patient testimonials. The information on this website has been designed for patients, healthcare providers, researchers and the general public.

The Consumer Guide to Clinical Trials factsheet helps consumers (patients and the general public) to better understand clinical trials and participation in clinical trials in Australia. The factsheet was funded by the department.

What do Australians think about Clinical Trials?

The department funded two activities to understand what Australians think about clinical trials and how they prefer to receive information:

These activities were undertaken to identify the most effective messages and methods of communicating with the Australian public for influencing behaviour regarding participation in clinical trials.

Enquiries

Email biotechnologies@industry.gov.au or write to:
Manager, Biotechnology Section
Advanced Manufacturing Branch
Department of Industry and Science
GPO Box 9839
Canberra ACT 2601

Share this Page